Esculentin-2CHa peptide and analogues thereof
US10202427B2 · kind B2 · utility
0Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 2015 |
| Grant date | Feb 12, 2019 |
| Priority date | — |
| Expiry date | Feb 2, 2035 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to an esculentin-2CHa peptide and analogs thereof, and the use each thereof in the treatment of diabetes, for example type 2 diabetes; insulin resistance; obesity, and/or hypercholesterolemia. Also disclosed is a pharmaceutical composition comprising peptides and analogs according to the present invention; use of peptides and analogs according to the present invention for the manufacture of a medicament for the treatment of diabetes, insulin resistance, obesity, and/or hypercholesterolemia; and methods of treating diabetes, insulin resistance, obesity, and/or hypercholesterolemia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.